Coelenterazine 400a

What We Offer

Coelenterazine 400a

Coelenterazine 400a | 70217-82-2

Catalog Number A14-0006
Category Calcium, Chloride Indictors and Other indicators
Molecular Formula C26H21N3O
Molecular Weight 391.5
Catalog Number Size Price Quantity
A14-0006 -- $--

Product Introduction

Coelenterazine 400a is a derivative of coelenterazine that produces chemiluminescence displayed by the Aequorin protein in the presence of Ca2+. It is used in BRET study as an indicator for intracelluar Ca2+.

Chemical Information

Synonyms 6-phenyl-2,8-bis(phenylmethyl)-imidazo[1,2-a]pyrazin-3(7H)-one; BlueSyn C
Purity ≥95%
IUPAC Name 2,8-dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3-ol
Canonical SMILES C1=CC=C(C=C1)CC2=C3N=C(C(=O)N3C=C(N2)C4=CC=CC=C4)CC5=CC=CC=C5
InChI InChI=1S/C26H21N3O/c30-26-23(17-20-12-6-2-7-13-20)28-25-22(16-19-10-4-1-5-11-19)27-24(18-29(25)26)21-14-8-3-9-15-21/h1-15,18,27H,16-17H2
InChI Key MWOYPGFRXPPBOX-UHFFFAOYSA-N
Appearance Solid Powder
  • Product Specification
  • Application
Emission 395 nm
Storage Store at -20°C

Coelenterazine 400a, a luminescent substrate renowned for its applications in bioluminescence studies and biological assays, offers a plethora of uses. Below are four key applications of Coelenterazine 400a:

Bioluminescence Imaging: Illuminating the realms of live cell and animal imaging, Coelenterazine 400a emerges as a quintessential tool for delving into gene expression, protein-protein interactions, and cellular functions in real-time. Upon entering cells housing luciferase enzymes, it triggers vibrant bioluminescent signals that unveil biological processes with vivid clarity, enabling quantitative analysis.

Reporter Gene Assays: Serving as the cornerstone for reporter gene assays, Coelenterazine 400a steps into the realm of scrutinizing the activity of specific promoters or DNA regulatory elements. The bioluminescent signals emanating in the presence of luciferase tags serve as guiding lights, illuminating transcriptional activities and aiding in the nuanced assessment of gene regulation intricacies. This application stands as a linchpin for untangling the elaborate patterns of gene expression and sifting through potential drug candidates with a discerning eye for detail.

Calcium Signaling Studies: Spearheading the frontier of calcium signaling research, Coelenterazine 400a assumes a pivotal role in quantifying intracellular calcium levels. Collaborating with aequorin-based calcium indicators, it radiates light upon binding to calcium ions, offering a visual depiction of calcium fluxes within the cellular milieu. This functionality acts as a foundational pillar for exploring diverse physiological processes, such as muscle contraction, neurotransmission, and cell proliferation, shedding luminous insights on the complexities of cellular orchestration.

Pathogen Detection: Embracing the challenge of detecting pathogens, Coelenterazine 400a takes the spotlight in diagnostic assays aimed at pinpointing pathogenic microorganisms. Through its amalgamation with specific luciferase enzymes, a bioluminescent reaction unfurls in the presence of the target pathogen, culminating in a detectable signal. This method marries heightened sensitivity and specificity, rendering it a potent tool for swiftly identifying microbial invaders in clinical and environmental samples.

Computed Properties

XLogP3 6.2
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 5
Exact Mass 391.168462302 g/mol
Monoisotopic Mass 391.168462302 g/mol
Topological Polar Surface Area 50.4Ų
Heavy Atom Count 30
Formal Charge 0
Complexity 524
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication NumberTitlePriority Date
US-2022373540-A1 Reagent kit containing polypeptide for use in detection of intermolecular interactions 2021-05-19
US-2022396830-A1 Bioluminescent detection of dna synthesis 2021-05-13
EP-4089413-A1 Method for determining the binding of an antibody to the complement component 1q (c1q) 2021-05-12
WO-2022238486-A1 Method for determining the binding of an antibody to the complement component 1q (c1q) 2021-05-12
JP-2022123828-A Polypeptide having luciferase activity 2021-02-12
cartIcon
Inquiry Basket